These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28001064)

  • 21. An overview of molecular fingerprint similarity search in virtual screening.
    Muegge I; Mukherjee P
    Expert Opin Drug Discov; 2016; 11(2):137-48. PubMed ID: 26558489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase.
    Wouters R; Tian J; Herdewijn P; De Jonghe S
    ChemMedChem; 2019 Jan; 14(2):237-254. PubMed ID: 30548533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intuitive ordering of scaffolds and scaffold similarity searching using scaffold keys.
    Ertl P
    J Chem Inf Model; 2014 Jun; 54(6):1617-22. PubMed ID: 24846291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries.
    Lee ML; Schneider G
    J Comb Chem; 2001; 3(3):284-9. PubMed ID: 11350252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computer-Aided Drug Discovery from Marine Compounds: Identification of the Three-Dimensional Structural Features Responsible for Antimalarial Activity.
    Fattorusso C; Persico M; Rondinelli F; Orteca N; Di Dato A
    Prog Mol Subcell Biol; 2017; 55():105-158. PubMed ID: 28238037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concepts and applications of "natural computing" techniques in de novo drug and peptide design.
    Hiss JA; Hartenfeller M; Schneider G
    Curr Pharm Des; 2010 May; 16(15):1656-65. PubMed ID: 20222857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ScafBank: a public comprehensive Scaffold database to support molecular hopping.
    Yan BB; Xue MZ; Xiong B; Liu K; Hu DY; Shen JK
    Acta Pharmacol Sin; 2009 Feb; 30(2):251-8. PubMed ID: 19151741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM; Ridderström M; Luthman K; Zamora I
    J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design.
    Shivani ; Abdul Rahaman TA; Chaudhary S
    Drug Discov Today; 2024 Sep; 29(9):104115. PubMed ID: 39067613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational scaffold hopping: cornerstone for the future of drug design?
    Bajorath J
    Future Med Chem; 2017 May; 9(7):629-631. PubMed ID: 28485634
    [No Abstract]   [Full Text] [Related]  

  • 32. Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping.
    Ertl P
    Bioorg Med Chem; 2012 Sep; 20(18):5436-42. PubMed ID: 22436390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method for effective virtual screening and scaffold-hopping in chemical compounds.
    Wale N; Karypis G; Watson IA
    Comput Syst Bioinformatics Conf; 2007; 6():403-14. PubMed ID: 17951843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaffold hopping towards potent and selective JAK3 inhibitors: discovery of novel C-5 substituted pyrrolopyrazines.
    de Vicente J; Lemoine R; Bartlett M; Hermann JC; Hekmat-Nejad M; Henningsen R; Jin S; Kuglstatter A; Li H; Lovey AJ; Menke J; Niu L; Patel V; Petersen A; Setti L; Shao A; Tivitmahaisoon P; Vu MD; Soth M
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4969-75. PubMed ID: 25262541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-Aided Drug Design: An Overview.
    Talevi A
    Methods Mol Biol; 2018; 1762():1-19. PubMed ID: 29594764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry.
    La Monica G; Bono A; Alamia F; Lauria A; Martorana A
    Bioorg Med Chem; 2024 Jul; 109():117791. PubMed ID: 38870715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.
    Zhao H
    Drug Discov Today; 2007 Feb; 12(3-4):149-55. PubMed ID: 17275735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo design - hop(p)ing against hope.
    Schneider G
    Drug Discov Today Technol; 2013 Dec; 10(4):e453-60. PubMed ID: 24451634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective CB2 receptor agonists. Part 1: the identification of novel ligands through computer-aided drug design (CADD) approaches.
    Hickey ER; Zindell R; Cirillo PF; Wu L; Ermann M; Berry AK; Thomson DS; Albrecht C; Gemkow MJ; Riether D
    Bioorg Med Chem Lett; 2015 Feb; 25(3):575-80. PubMed ID: 25556098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.